Skip to content

Azacitidine

Generic Medicine With 3 Brands Available In Bangladesh. Read What It Is For And How It Is Taken, Then Compare The Brands By Strength, Maker And Price.

Generic Guide

About Azacitidine

What This Generic Is For, How It Is Taken, And What To Watch For.

Indications

Azacitidine is a nucleoside metabolic inhibitor indicated for the treatment of patients with the following FAB myelodysplastic syndrome (MDS) subtypes: Refractory anemia (RA) or refractory anemia with ringed sideroblasts (RARS) (if accompanied by neutropenia or thrombocytopenia or requiring transfusions), refractory anemia with excess blasts (RAEB), refractory anemia with excess blasts in transformation (RAEB-T), and chronic myelomonocytic leukemia (CMMoL).

Dosage And Administration

Injection: The recommended starting dose for the first treatment cycle, for all patients regardless of baseline hematology values, is azacitidine 75 mg/m2 daily for 7 days to be administered by subcutaneous (SC) injection or intravenous (IV) infusion. Premedicate for nausea and vomiting. Repeat cycles every 4 weeks. After 2 cycles, may increase dose to 100 mg/m2 if no beneficial effect is seen and no toxicity other than nausea and vomiting has occurred. Patients should be treated for a minimum of 4 to 6 cycles. Complete or partial response may require additional treatment cycles. Continue treatment as long as the patient continues to benefit. Patients should be monitored for hematologic response and renal toxicities, with dosage delay or reduction as appropriate. Tablet: Administer Azacitidine 300 mg orally once daily on Days 1 through 14 of each 28-day cycle. Administer an antiemetic before each dose for at least the first 2 cycles. Pediatric Use: Safety and effectiveness in pediatric patients have not been established.

Side Effects

Most common adverse reactions (>30%) by SC route are: nausea, anemia, thrombocytopenia, vomiting, pyrexia, leukopenia, diarrhea, injection site erythema, constipation, neutropenia and ecchymosis. Most common adverse reactions by IV route also included petechiae, rigors, weakness and hypokalemia.

Precautions And Warnings

Anemia, neutropenia and thrombocytopenia. Perform complete blood counts (CBC) prior to each treatment cycle and as needed to monitor response and toxicity. Hepatotoxicity: Use with caution in patients with severe preexisting liver impairment. Renal abnormalities. Monitor patients with renal impairment for toxicity since azacitidine and its metabolites are primarily excreted by the kidneys. Monitor liver chemistries and serum creatinine prior to initiation of therapy and with each cycle. Azacitidine may cause fetal harm when administered to a pregnant woman. Women of childbearing potential should be apprised of the potential hazard to a fetus. Men should be advised not to father a child while receiving Azacitidine.

Pregnancy And Lactation

Pregnancy Category D. Azacitidine may cause fetal harm when administered to a pregnant woman. It is not known whether azacitidine or its metabolites are excreted in human milk. Because of the potential for tumorigenicity shown for azacitidine in animal studies and the potential for serious adverse reactions in nursing infants, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into consideration the importance of the drug to the mother.

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250

Clinical Details

BestinMeds shares medicine information to help you compare. It does not replace advice from your doctor or pharmacist.

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250

Available Brand Names: 3

Sorted By
IV/SC Injection

Azacitid 100 mg/vial

Generic: Azacitidine

6500.00Taka / 100 mg vial

View Medicine
Tablet

Azacitid 300 mg

Generic: Azacitidine

87.50Taka / Unit

View Medicine
IV/SC Injection

Azacitidine 100 mg/vial

Generic: Azacitidine

9400.00Taka / 100 mg vial

View Medicine

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250